top
Search terms
Results 1 - 1 of 1 - ordered by :
Ehjournal

The CANTOS trial has addressed this and showed convincingly that in the absence of any change of LDL-cholesterol, Canakinumab, a monoclonal antibody targeting interleukin-1β, improves outcome ...

European Heart Journal, Lüscher, Thomas F

Date : 07/10/2018 Item size : 241927 bytes